Purchases and Sales Made in Q2 2023 in Bio Xcel Therapeutics, Inc. (BTAI)
This table provides information about the institutional ownership of Bio Xcel Therapeutics, Inc. (BTAI) during Q2 2023. The information is specifically focused on institutions that hold shares of BioXcel Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 10, 2023
Q2 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Aug 03, 2023
Q2 2023
|
Cwm, LLC
|
SELL
|
- |
-10- 11.11% |
$63.9 - $286
|
80
$170
|
|
Aug 21, 2023
Q2 2023
|
California State Teachers Retirement System
West Sacramento, CA |
SELL
|
- |
-99- 0.41% |
$633 - $2.83K
|
24.2K
$51.4K
|
|
Aug 14, 2023
Q2 2023
|
Virtus ETF Advisers LLC
New York, NY |
SELL
|
- |
-189- 3.57% |
$1.21K - $5.4K
|
5.11K
$10.8K
|
|
Aug 08, 2023
Q2 2023
|
Rhumbline Advisers
Boston, MA |
SELL
|
- |
-5.23K- 15.63% |
$33.4K - $150K
|
28.3K
$59.9K
|
|
Aug 14, 2023
Q2 2023
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-14.1K- 51.04% |
$90.2K - $404K
|
13.5K
$28.7K
|
|
Aug 14, 2023
Q2 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-19.6K- 11.98% |
$125K - $560K
|
144K
$305K
|
|
May 14, 2024
Q2 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-19.6K- 11.98% |
$125K - $560K
|
144K
$305K
|
|
Aug 09, 2023
Q2 2023
|
Hennion & Walsh Asset Management, Inc.
|
SELL
|
- |
-20K- 52.73% |
$128K - $571K
|
17.9K
$38K
|
|
Jul 20, 2023
Q2 2023
|
Davenport & CO LLC
|
SELL
|
- |
-20.6K- 25.64% |
$132K - $588K
|
59.7K
$127K
|
|
Aug 09, 2023
Q2 2023
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-23.8K- 38.68% |
$152K - $679K
|
37.7K
$79.9K
|
|
Aug 14, 2023
Q2 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-37.2K- 28.61% |
$238K - $1.06M
|
92.9K
$197K
|
|
Aug 14, 2023
Q2 2023
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-46.5K- 75.86% |
$297K - $1.33M
|
14.8K
$31.4K
|
|
Jul 18, 2023
Q2 2023
|
Allspring Global Investments Holdings, LLC
|
SELL
|
- |
-47.7K- 96.67% |
$305K - $1.36M
|
1.64K
$3.48K
|
|
Aug 11, 2023
Q2 2023
|
Ubs Group Ag
|
SELL
|
- |
-49.4K- 30.79% |
$315K - $1.41M
|
111K
$235K
|
|
Aug 10, 2023
Q2 2023
|
Citigroup Inc
|
SELL
|
- |
-58.9K- 49.52% |
$376K - $1.68M
|
60.1K
$127K
|
|
Aug 14, 2023
Q2 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-69.9K- 82.79% |
$447K - $2M
|
14.5K
$30.8K
|
|
Aug 14, 2023
Q2 2023
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-69.9K- 20.51% |
$447K - $2M
|
271K
$575K
|
|
Jul 19, 2023
Q2 2023
|
Artemis Investment Management LLP
|
SELL
|
- |
-86.4K- 8.81% |
$552K - $2.47M
|
895K
$1.9M
|
|
Aug 14, 2023
Q2 2023
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-129K- 6.22% |
$827K - $3.7M
|
1.95M
$4.14M
|
|
Aug 14, 2023
Q2 2023
|
Wellington Management Group LLP
Boston, MA |
SELL
|
- |
-131K- 9.84% |
$839K - $3.75M
|
1.2M
$2.55M
|
|
Aug 14, 2023
Q2 2023
|
Driehaus Capital Management LLC
Chicago, IL |
SELL
|
- |
-367K- 94.28% |
$2.34M - $10.5M
|
22.2K
$47.1K
|